Skip to content
Trial Eligibility
Menu

Multiple Sclerosis Clinical Trials near Bethesda, MD

22 studies for Multiple Sclerosis are recruiting at 35 sites within 50 miles of Bethesda, Maryland, according to ClinicalTrials.gov data processed .

Distances are city-level approximations. See all Multiple Sclerosis trials in the US or all trials near Bethesda.

Your ZIP is looked up in your browser. We don't receive or store it.

Recruiting now

Multiple Sclerosis studies enrolling near Bethesda

Showing 22 studies, nearest first.
  1. A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis

    NCT07225504

    • Phase 3
    • Ages 18 to 65 years
    • Sex: All

    Nearest sites: Mid Atlantic Epilepsy and Sleep Ctr (Bethesda, MD); Georgetown University Hospital (Washington D.C., DC)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    4 sites within 50 mi
  2. Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

    NCT03816345

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest sites: National Cancer Institute Developmental Therapeutics Clinic (Bethesda, MD); MedStar Georgetown University Hospital (Washington D.C., DC)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  3. A Study on the Safety of Ozanimod Exposure in Pregnant Women and Their Offspring

    NCT05170126

    • Observational
    • Ages Any age
    • Sex: Female

    Nearest sites: Evidera (Bethesda, MD); Evidera INC. (Bethesda, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  4. Magnetic Resonance Imaging (MRI) to Evaluate Activity of Multiple Sclerosis (MS)

    NCT00001248

    • Observational
    • Ages 18 to 120 years
    • Sex: All
    • Accepts healthy volunteers

    Nearest site: National Institutes of Health Clinical Center (Bethesda, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  5. Comprehensive Multimodal Analysis of Neuroimmunological Diseases of the Central Nervous System

    NCT00794352

    • Observational
    • Ages 1 month to 99 years
    • Sex: All
    • Accepts healthy volunteers

    Nearest site: National Institutes of Health Clinical Center (Bethesda, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  6. Genes and Environment in Multiple Sclerosis

    NCT01353547

    • Observational
    • Ages 18 years and older
    • Sex: All
    • Accepts healthy volunteers

    Nearest site: National Institute of Neurological Disorders and Stroke (Bethesda, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  7. Natural History Study of Progressive Multifocal Leukoencephalopathy (PML)

    NCT01730131

    • Observational
    • Ages 2 to 120 years
    • Sex: All
    • Accepts healthy volunteers

    Nearest site: National Institutes of Health Clinical Center (Bethesda, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  8. Pathological Basis of MRI Signal Changes in Multiple Sclerosis

    NCT02659956

    • Observational
    • Ages 18 to 120 years
    • Sex: All
    • Accepts healthy volunteers

    Nearest site: National Institutes of Health Clinical Center (Bethesda, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  9. Effect of Corticosteroids on Inflammation at the Edge of Acute Multiple Sclerosis Plaques

    NCT02784210

    • Phase 2
    • Ages 18 to 120 years
    • Sex: All

    Nearest site: National Institutes of Health Clinical Center (Bethesda, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  10. Targeting Residual Activity By Precision, Biomarker-Guided Combination Therapies of Multiple Sclerosis (TRAP-MS)

    NCT03109288

    • Phase 1/2
    • Ages 18 to 120 years
    • Sex: All

    Nearest site: National Institutes of Health Clinical Center (Bethesda, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  11. Central Nervous System Uptake of Anti-CD8+ T Cell Minibodies in Multiple Sclerosis and Progressive Multifocal Leukoencephalopathy

    NCT05849467

    • Phase 1
    • Ages 18 to 120 years
    • Sex: All

    Nearest site: National Institutes of Health Clinical Center (Bethesda, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  12. A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

    NCT06433752

    • Observational
    • Ages 18 years and older
    • Sex: All

    Nearest sites: TG Therapeutics Investigational Trial Site (Washington D.C., DC); TG Therapeutics Investigational Trial Site (Vienna, VA)

    Distance to nearest recruiting site
    ~7 mi (city-level)
    Recruiting sites
    4 sites within 50 mi
  13. Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab

    NCT05877963

    • Phase 3
    • Ages 18 to 65 years
    • Sex: All

    Nearest sites: TG Therapeutics Investigational Trial Site (Washington D.C., DC); TG Therapeutics Investigational Trial Site (Vienna, VA)

    Distance to nearest recruiting site
    ~7 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  14. Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.

    NCT06846281

    • Phase 3
    • Ages 40 to 70 years
    • Sex: All

    Nearest sites: Medstar Washington Hospital Center (Washington D.C., DC); MedStar Montgomery Medical Center (Olney, MD)

    Distance to nearest recruiting site
    ~7 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  15. An Open-label Study of AZD0120 in Adults With Multiple Sclerosis

    NCT07224373

    • Phase 1
    • Ages 18 to 60 years
    • Sex: All

    Nearest site: Research Site (Washington D.C., DC)

    Distance to nearest recruiting site
    ~7 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  16. RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

    NCT07002034

    • Phase 2
    • Ages 18 to 80 years
    • Sex: All

    Nearest sites: Sunstone Therapies, PC (Rockville, MD); Sheppard Pratt (Towson, MD)

    Distance to nearest recruiting site
    ~8 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  17. Solriamfetol for the Treatment of Multiple Sclerosis Fatigue

    NCT06170970

    • Phase 2
    • Ages 18 to 60 years
    • Sex: All

    Nearest site: Johns Hopkins University (Baltimore, MD)

    Distance to nearest recruiting site
    ~34 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  18. The SetPoint System as a Pro-Remyelination Therapy for Relapsing-Remitting Multiple Sclerosis: A Pilot Study

    NCT06796504

    • Interventional
    • Ages 22 to 60 years
    • Sex: All

    Nearest site: Johns Hopkins School of Medicine (Baltimore, MD)

    Distance to nearest recruiting site
    ~34 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  19. Exploration of Novel Imaging Biomarkers on OCT for Ublituximab Treatment Response in Multiple Sclerosis

    NCT06864936

    • Interventional
    • Ages 18 to 65 years
    • Sex: All

    Nearest site: University of Maryland, Baltimore (Baltimore, MD)

    Distance to nearest recruiting site
    ~34 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  20. Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis

    NCT07325292

    • Phase 3
    • Ages 18 to 60 years
    • Sex: All

    Nearest site: Baltimore Veterans Affairs Medical Center- Site Number : 8400163 (Baltimore, MD)

    Distance to nearest recruiting site
    ~34 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  21. Study of Ublituximab for Ocrelizumab Wearing-Off in Multiple Sclerosis

    NCT07389590

    • Phase 4
    • Ages 18 to 65 years
    • Sex: All

    Nearest site: Johns Hopkins University (Baltimore, MD)

    Distance to nearest recruiting site
    ~34 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  22. Targeting Agonists of Glucagon-like Peptide-1 Receptor for Multiple Sclerosis

    NCT07497399

    • Phase 2
    • Ages 18 to 60 years
    • Sex: All

    Nearest site: Johns Hopkins University (Baltimore, MD)

    Distance to nearest recruiting site
    ~34 mi (city-level)
    Recruiting sites
    1 site within 50 mi

FAQ

Common questions

What is a clinical trial?
A clinical trial is a research study in people that tests a medical, surgical or behavioral intervention, such as an investigational drug or device. Observational studies are also listed: they collect information without assigning a treatment. Read how clinical trials work.
Is there compensation for joining a Multiple Sclerosis clinical trial?
Compensation for time and travel may be available, but it varies by study and some studies offer none. The amount and schedule are reviewed by an ethics board and described in the consent form. See compensation in clinical trials.
How do I check if I'm eligible?
Each study lists age, sex and other inclusion and exclusion criteria on its ClinicalTrials.gov record. Only the study team can confirm eligibility, usually through a screening call or visit. Talk with your own doctor before joining any study.

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.